Slightly fewer Americans want to reduce cravings through medication
The Ipsos Consumer Tracker asks Americans questions about culture, the economy and the forces that shape our lives. Here's one thing we learned this week.
Why we asked about craving-reducing medications: GLP-1s are very much in the news at the moment, as the Trump administration is working with pharmaceutical companies to make these drugs more widely available at slightly lower costs – and also fast-tracking approval of oral versions, which could be a real game changer.
What we found: Across the board, we see slight decreases in interest for the craving-reduction medications. About half were interested in reducing sweets (the most sought-after use), followed by controlling eating for weight loss, salty snacks, alcohol and coffee. But as we said, analysts are watching what the likely release of pill versions will do to demand. Stay tuned.
More insights from this wave of the Ipsos Consumer Tracker:
Fewer Americans are planning to drive for the holidays
More people are using AI chatbots, but for what?
The Ipsos Vibe Check: Here's how Americans feel about the government this week
The Ipsos Care-o-Meter: What does America know about vs. what does America care about?
